+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients



Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients



Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(7): 1181-1185



The c-erbB-2 oncogene, is a member of tyrosine kinase oncogene family and expected to play a role in the regulation of cell growth. In the present study, prognostic significance of the expression of c-erbB-2 oncoprotein was investigated by immunocytochemical assay with 130 primary breast cancer patients. The positive expression of c-erbB-2 oncoprotein was found in 53 out of 130 patients (40.8%). There was no significant correlation between expression of c-erbB-2 oncoprotein and conventional prognostic factors, estrogen receptor (ER), axillary lymph node metastasis and epidermal growth factor receptor (EGFR). Relapse free survival rate of the patients with positive c-erbB-2 expression was significantly worse than those with negative at 49 month after operation. Similar result was found in overall survival rate but the difference was not significant. Furthermore, when patients were stratified by regional nodal status, in the patients with lymph node metastasis, the prognosis of the patients with positive c-erbB-2 expression was significantly worse than those with negative, while no significant difference was found in the patients without lymph node metastasis. These results suggest that c-erbB-2 oncoprotein may act as a prognostic factor independently, predicting the prognosis of breast cancer patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041088846

Download citation: RISBibTeXText

PMID: 1675844


Related references

Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients. American Journal of Surgery 164(4): 323-326, 1992

Clinico-pathological study on the expression of c-erbB-2 oncoprotein in human breast cancer, with reference to prognostic significance. Medical Journal of Hiroshima University 40(5): 435-449, 1992

Prognostic significance of c erbb 2 oncoprotein expression in breast carcinomas. Proceedings of the American Association for Cancer Research Annual Meeting 31: 48, 1990

Prognostic significance of Helix pomatia lectin and c-erbB-2 oncoprotein in human breast cancer. British Journal of Cancer 68(3): 621-626, 1993

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Research 49(8): 2087-2090, 1989

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value. Breast Cancer Research and Treatment 51(2): 109-119, 1999

C-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: Prognostic value. Breast Cancer Research & Treatment 51(2): 109-119, Sept, 1998

Prognostic significance of c erbb 2 oncoprotein overexpression in breast carcinoma patients and its immunological role. Proceedings of the American Association for Cancer Research Annual Meeting 33: 312, 1992

Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer. Cancer Research and Treatment 36(4): 240-245, 2004

C erbb 2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in axillary node positive breast cancer patients. Breast Cancer Research & Treatment 19(2): 177, 1991

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. Journal of Clinical Oncology 10(5): 686-695, 1992

Prognostic value of the expression of the c erbb 2 oncoprotein onc compared with epidermal growth factor receptor egfr dna ploidy p and conventional pathologic features in breast cancer bc. Proceedings of the American Association for Cancer Research Annual Meeting 33: 213, 1992

Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors. International Journal of Oncology 18(4): 793-800, 2001

C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer. Cancer 69(12): 2953-2960, 1992

C-erbB-2 oncogene expression detected by fish in correlation with membrane expression of c-erbB-2 oncoprotein in patients with breast carcinomas. Virchows Archiv 435(3): 198, Sept, 1999